KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,025,079 | +15.3% | 346,867 | -6.6% | 0.00% | 0.0% |
| Q2 2023 | $5,227,551 | +30.8% | 371,275 | -0.1% | 0.00% | +100.0% |
| Q1 2023 | $3,997,469 | -25.2% | 371,512 | +4.2% | 0.00% | -50.0% |
| Q4 2022 | $5,343,000 | +11.2% | 356,616 | -4.6% | 0.00% | 0.0% |
| Q3 2022 | $4,803,000 | -81.1% | 373,990 | -72.7% | 0.00% | -75.0% |
| Q1 2021 | $25,385,000 | -39.4% | 1,371,430 | -42.2% | 0.01% | -46.7% |
| Q4 2020 | $41,901,000 | +28.1% | 2,371,236 | +11.1% | 0.02% | +15.4% |
| Q3 2020 | $32,712,000 | -13.8% | 2,135,259 | +43.4% | 0.01% | -18.8% |
| Q2 2020 | $37,936,000 | +276.4% | 1,488,839 | +128.7% | 0.02% | +220.0% |
| Q1 2020 | $10,078,000 | -20.7% | 651,069 | -43.4% | 0.01% | 0.0% |
| Q4 2019 | $12,713,000 | +122.4% | 1,149,578 | +71.2% | 0.01% | +66.7% |
| Q3 2019 | $5,716,000 | -43.4% | 671,638 | -10.0% | 0.00% | -40.0% |
| Q2 2019 | $10,100,000 | +4.6% | 746,010 | +39.5% | 0.01% | +25.0% |
| Q1 2019 | $9,656,000 | +13.6% | 534,625 | +76.7% | 0.00% | 0.0% |
| Q4 2018 | $8,501,000 | -9.8% | 302,640 | -18.1% | 0.00% | +33.3% |
| Q3 2018 | $9,426,000 | -24.8% | 369,682 | -48.8% | 0.00% | -50.0% |
| Q2 2018 | $12,532,000 | – | 722,291 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |